{"id":324534,"date":"2022-10-09T13:39:54","date_gmt":"2022-10-09T11:39:54","guid":{"rendered":"https:\/\/medizinonline.com\/le-traitement-de-la-llc-r-r-lignes-directrices-etudes-et-rapports-de-cas\/"},"modified":"2022-10-09T13:39:54","modified_gmt":"2022-10-09T11:39:54","slug":"le-traitement-de-la-llc-r-r-lignes-directrices-etudes-et-rapports-de-cas","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/le-traitement-de-la-llc-r-r-lignes-directrices-etudes-et-rapports-de-cas\/","title":{"rendered":"Le traitement de la LLC R\/R : lignes directrices, \u00e9tudes et rapports de cas"},"content":{"rendered":"<p><strong>Le d\u00e9veloppement de nouvelles substances cibl\u00e9es permet de remplacer les chimioth\u00e9rapies classiques par des approches plus tol\u00e9rantes<\/strong><strong><br \/>\n  <sup>1<\/sup><br \/>\n<\/strong>.&nbsp;<strong>Dans ce webcast, le Dr Marc Heizmann, m\u00e9decin-chef en h\u00e9matologie et m\u00e9decine transfusionnelle \u00e0 l&#8217;h\u00f4pital cantonal d&#8217;Aarau, parle des directives de traitement de la LLC R\/R, pr\u00e9sente des \u00e9tudes sur la th\u00e9rapie cibl\u00e9e et pr\u00e9sente deux rapports de cas.&nbsp;<\/strong><\/p>\n<p> <!--more--> <\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\" size-full wp-image-19558\" alt=\"\" src=\"https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0.png\" style=\"height:350px; width:1100px\" width=\"1100\" height=\"350\" srcset=\"https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0.png 1100w, https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0-800x255.png 800w, https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0-120x38.png 120w, https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0-90x29.png 90w, https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0-320x102.png 320w, https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0-560x178.png 560w\" sizes=\"(max-width: 1100px) 100vw, 1100px\" \/><\/p>\n<p><iframe frameborder=\"0\" height=\"1200\" data-src=\"https:\/\/player.vimeo.com\/video\/758630881?h=f182288213&amp;badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479\" title=\"Heizmann_DE_neu_20220928.mp4\" width=\"1920\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Dr. sc. nat. Katja Becker<\/strong><\/p>\n<p>Cet article a \u00e9t\u00e9 r\u00e9dig\u00e9 avec le soutien financier de AbbVie AG, Alte Steinhauserstrasse 14, Cham.<\/p>\n<p>CH-VNCCLL-220057 08\/2022<\/p>\n<p><a href=\"https:\/\/assets.medizinonline.com\/sites\/default\/files\/20210318_kfi_venclyxto_v6_de_mar_2020_final_promomats_0.pdf\" target=\"_blank\" rel=\"noopener\">Information professionnelle succincte de Venclyxto\u00ae.&nbsp;<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Litt\u00e9rature<\/strong><\/p>\n<div><span style=\"font-size:9px\">1. Bewarder et al. Options de traitement actuelles dans la LLC. Cancers (B\u00e2le). 2021 May 19;13(10):2468.<\/span><\/div>\n<p>&nbsp;<\/p>\n<p>Les r\u00e9f\u00e9rences peuvent \u00eatre demand\u00e9es par les professionnels \u00e0&nbsp;<a href=\"mailto:medinfo.ch@abbvie.com\">medinfo.ch@abbvie.com<\/a>&nbsp;.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le d\u00e9veloppement de nouvelles substances cibl\u00e9es permet de remplacer les chimioth\u00e9rapies classiques par des approches plus tol\u00e9rantes 1 .&nbsp;Dans ce webcast, le Dr Marc Heizmann, m\u00e9decin-chef en h\u00e9matologie et m\u00e9decine&hellip;<\/p>\n","protected":false},"author":14,"featured_media":124094,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Leuc\u00e9mie lympho\u00efde chronique r\u00e9cidivante\/r\u00e9fractaire","footnotes":""},"category":[11541,11527,11373,11539,11389,11549],"tags":[],"powerkit_post_featured":[],"class_list":["post-324534","post","type-post","status-publish","format-standard","has-post-thumbnail","category-cases-fr","category-etudes","category-hematologie","category-interviews-fr","category-oncologie","category-rx-fr","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-04 04:35:14","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":324541,"slug":"il-trattamento-della-llc-r-r-linee-guida-studi-e-rapporti-di-casi","post_title":"Il trattamento della LLC R\/R: linee guida, studi e rapporti di casi","href":"https:\/\/medizinonline.com\/it\/il-trattamento-della-llc-r-r-linee-guida-studi-e-rapporti-di-casi\/"},"pt_PT":{"locale":"pt_PT","id":324512,"slug":"o-tratamento-do-r-r-cll-orientacoes-estudos-e-relatorios-de-casos","post_title":"O tratamento do R\/R CLL: orienta\u00e7\u00f5es, estudos e relat\u00f3rios de casos","href":"https:\/\/medizinonline.com\/pt-pt\/o-tratamento-do-r-r-cll-orientacoes-estudos-e-relatorios-de-casos\/"},"es_ES":{"locale":"es_ES","id":324521,"slug":"el-tratamiento-de-la-llc-r-r-directrices-estudios-y-casos-clinicos","post_title":"El tratamiento de la LLC R\/R: directrices, estudios y casos cl\u00ednicos","href":"https:\/\/medizinonline.com\/es\/el-tratamiento-de-la-llc-r-r-directrices-estudios-y-casos-clinicos\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/324534","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=324534"}],"version-history":[{"count":0,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/324534\/revisions"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=324534"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=324534"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=324534"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=324534"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}